11-95923947-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016156.6(MTMR2):āc.8A>Gā(p.Lys3Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000834 in 1,558,762 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K3T) has been classified as Benign.
Frequency
Consequence
NM_016156.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MTMR2 | NM_016156.6 | c.8A>G | p.Lys3Arg | missense_variant | 1/15 | ENST00000346299.10 | |
MTMR2 | NM_001243571.2 | c.-476A>G | 5_prime_UTR_variant | 1/18 | |||
MTMR2 | NM_201278.3 | c.-403A>G | 5_prime_UTR_variant | 1/17 | |||
MTMR2 | NM_201281.3 | c.-280A>G | 5_prime_UTR_variant | 1/16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MTMR2 | ENST00000346299.10 | c.8A>G | p.Lys3Arg | missense_variant | 1/15 | 1 | NM_016156.6 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152114Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000311 AC: 5AN: 160886Hom.: 0 AF XY: 0.0000579 AC XY: 5AN XY: 86292
GnomAD4 exome AF: 0.00000782 AC: 11AN: 1406648Hom.: 0 Cov.: 47 AF XY: 0.0000158 AC XY: 11AN XY: 694654
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152114Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74302
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 4 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 01, 2021 | This sequence change replaces lysine with arginine at codon 3 of the MTMR2 protein (p.Lys3Arg). The lysine residue is weakly conserved and there is a small physicochemical difference between lysine and arginine. This variant is present in population databases (rs3824874, ExAC 0.01%). This variant has not been reported in the literature in individuals affected with MTMR2-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MTMR2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at